info@seagull-health.com
SeagullHealth
语言:
search
new
What is Canagliflozin Hydrochloride (Canaglu)?
502
Article source: Seagull Pharmacy
Nov 24, 2025

Canagliflozin Hydrochloride (Canaglu) is a novel sodium-glucose cotransporter 2 (SGLT2) inhibitor developed by Bayer, primarily indicated for the treatment of type 2 diabetes mellitus. As a key member of oral hypoglycemic agents, its unique mechanism of action and clinical advantages provide a new option for diabetes management.

What is Canagliflozin Hydrochloride (Canaglu)?

Drug Classification and Mechanism of Action

Canagliflozin Hydrochloride belongs to the class of SGLT2 inhibitors. It selectively inhibits SGLT2 in the proximal convoluted tubule of the kidneys, reducing glucose reabsorption and promoting urinary glucose excretion, thereby lowering blood glucose levels.

Main Indications

Primarily used to improve glycemic control in adult patients with type 2 diabetes mellitus, either as monotherapy or in combination with other oral hypoglycemic agents.

In certain cases, it may also be used in combination with insulin to optimize glycemic management outcomes.

Specifications and Characteristics of Canagliflozin Hydrochloride (Canaglu)

Dosage Form and Strengths

Canagliflozin Hydrochloride is available as oral tablets, with common strengths including 100 mg and 300 mg.

The tablets are film-coated, presenting as round or oval in shape. Specific shape and color may vary by manufacturer.

Physical Characteristics Description

The tablet surface is usually imprinted with dosage markings for easy identification and differentiation.

100 mg tablets are mostly white or light-colored, while 300 mg tablets may be dark yellow or orange.

The tablets are hard in texture, odorless, and maintain stable physical properties under normal storage conditions.

Storage Methods for Canagliflozin Hydrochloride (Canaglu)

Storage Environment Requirements

Unopened medications should be stored in their original packaging at a temperature of 20-25°C (68-77°F). Short-term transportation is permitted within a temperature range of 15-30°C (59-86°F).

Avoid direct sunlight and humid environments.

Post-Opening Management

After opening, keep the bottle tightly capped and store in a dry place.

It is recommended to mark the opening date on the bottle. Generally, the medication should be used within 6 months after opening; refer to the package insert for the exact shelf life.

Special Precautions

Do not store the medication in high-humidity areas such as bathrooms or kitchens.

Ensure the medication is placed out of the reach of children to prevent accidental ingestion.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase Canagliflozin Hydrochloride (Canaglu)?
Canagliflozin Hydrochloride (Canaglu), as a new-generation oral hypoglycemic agent, plays an important role in the treatment of type 2 diabetes mellitus.How to Purchase Canagliflozin Hydrochloride (Ca...
Side Effects of Lurbinectedin (Zepzelca)
Lurbinectedin (Zepzelca) is an alkylating agent indicated for the maintenance treatment of extensive-stage small cell lung cancer (ES-SCLC) and for the treatment of patients with metastatic small cell...
What are the Precautions for Lurbinectedin (Zepzelca) Administration?
Lurbinectedin (Zepzelca) is an alkylating agent indicated for the maintenance treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) and for the treatment of patients with m...
Dosage and Administration of Lurbinectedin (Zepzelca)
Lurbinectedin (Zepzelca) is an innovative medication for the treatment of small cell lung cancer (SCLC). As a type of alkylating agent, it exerts antitumor activity through multiple mechanisms.Dosage ...
How to Use Canagliflozin Hydrochloride (Canaglu)
Canagliflozin Hydrochloride (Canaglu) is a new-generation sodium-glucose cotransporter 2 (SGLT2) inhibitor that provides an innovative solution for type 2 diabetes mellitus management through a unique...
What are the Side Effects of Canagliflozin Hydrochloride (Canaglu)?
Canagliflozin Hydrochloride (Canaglu) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that lowers blood glucose levels by inhibiting renal glucose reabsorption. Like all medications, canaglifloz...
How to Purchase Nitroxolin Capsules (Nitroxolinforte)?
Nitroxolin Capsules (Nitroxolinforte) is a prescription medication for the treatment of urinary tract infections, manufactured by MIP Pharma GmbH for the German market.How to Purchase Nitroxolin Capsu...
What is Nitroxolin Capsules (Nitroxolinforte)?
Nitroxolin Capsules (Nitroxolinforte) is an antibacterial medication specifically indicated for the treatment of urinary tract infections. As a quinolone derivative, it possesses a unique dual mechani...
Related Articles
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)
Elacestrant (Orserdu) is a selective estrogen receptor degrader (SERD), which provides an important treatment option for patients with estrogen receptor-positive, HER2-negative advanced or metastatic ...
What Are the Indications for Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel endocrine therapy agent that demonstrates significant value in the treatment of advanced breast cancer with specific gene mutations. As an estrogen receptor antagonist...
What Are the Purchase Channels for Elacestrant (Orserdu)?
With the advancement of medical technology, elacestrant (Orserdu), a targeted drug for breast cancer with specific gene mutations, has brought new treatment options for patients. As the first oral sel...
Adverse Reactions of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor indicated for the treatment of patients with advanced non-small cell lung cancer harboring MET gene mutations. By precisely inhibiting the act...
What are the Precautions for Capmatinib (Tabrecta) Administration?
Capmatinib (Tabrecta) is a targeted therapy drug for MET gene mutations, demonstrating significant efficacy in the treatment of advanced malignancies such as non-small cell lung cancer.What are the Pr...
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved